The Federal Trade Commission is suing Illumina, a gene sequencing firm, in an effort to stop its proposed $7.1 billion acquisition of life sciences firm Grail. 

A new study has reaffirmed that consumers don’t really shop around to find lower healthcare prices.

Higher star ratings may be associated with better patient outcomes in Medicare Advantage plans, according to a study published in Health Affairs.

A month and a half after hospitals were mandated to show their prices for shoppable services, anecdotal evidence shows some may be deeming the penalty of up to $300 per day insufficiently incentivizing.

A new alliance of powerful associations representing providers, payers, hospitals and employers has formed to push U.S. healthcare toward universal coverage.

Drug prices in the U.S. are significantly higher than those in peer countries, according to new research from RAND. In fact, compared with 32 other countries combined, drug prices in the U.S. are 256% higher.

The Biden-Harris administration is planning to sign two executive orders to provide healthcare relief for those needing insurance during the COVID-19 pandemic, as well as undo some Trump administration policies that undermined the Affordable Care Act.

Another quick field check has found the federal rule requiring hospitals to show their prices for shoppable services meeting with only spotty compliance since it went into effect Jan. 1.